StockGro Blogs

Posted inin IPO

Allchem Lifescience IPO Date, Price, GMP, Details
Allchem Lifescience IPO details out! Take a look at its valuation, market position, and expected listing updates.

Posted byby Priya Mehra
March 17, 2026
4 min

Allchem Lifescience IPO, a book-built/mainboard issue with SEBI’s approval, is raising capital with a fresh issue worth ₹190.00 crore and an offer-for-sale of 7,155,000...

Posted inin IPO

Speciality Medicines IPO Date, Price, GMP, Details
A niche pharma player with global reach is opening its doors to investors. Does Speciality Medicines have the right mix of growth and stability?

Posted byby Rohan Malhotra
March 17, 2026
5 min

The Speciality Medicines IPO aims to raise ₹29 crore from the market. It will issue 23,50,000 shares with a nominal value of ₹10. The...

Posted inin IPO

Juniper Green Energy IPO Date, Price, GMP, Details
Riding the 2026 IPO wave, Juniper Green Energy IPO is on its way to the stock market. Know the issue size, KPIs, and GMP trends in this blog!

Posted byby Rohan Malhotra
March 17, 2026
4 min

Juniper Green Energy IPO, approved by SEBI on 28 August 2025, is a book-built/mainboard issue, raising ₹3,000.00 crore, with only fresh shares, which are...

Posted inin Mutual Funds

What Is UTI Mutual Fund?: Performance, & How to Invest

Posted byby Anil Sharma
March 17, 2026
5 min

As of February 28, 2026, the Indian mutual fund industry manages assets worth roughly ₹82 lakh crore. Such a large pool of capital does...

Posted inin Market Spotlight

Sensex Rises 568 Points, Nifty Extends Recovery To Second Session
Market stayed choppy, but autos and metals lifted indices despite oil concerns.

Posted byby Rohan Malhotra
March 17, 2026
5 min

Nifty 50 rose 172.35 points, or 0.74%, to 23,581.15 Sensex gained 568 points, or 0.75%, to 76,070.84 Nifty MidCap rose 1.07% Nifty SmallCap gained...

Posted inin IPO

Tipco Engineering India IPO Date, Price, GMP, Details
Tipco Engineering India IPO puts an industrial machinery maker in focus. Strong growth is visible on paper, but do the business risks change the bigger picture?

Posted byby Rishi Gupta
March 17, 2026
6 min

Tipco Engineering India is entering the primary market with a book-built SME IPO that will be listed on the BSE SME platform. The issue...

Posted inin IPO

Amir Chand Jagdish Kumar IPO Date, Price, GMP, Details
A long-standing basmati rice exporter heads for the public markets. Here's what investors should know about Amir Chand Jagdish Kumar (Exports) IPO.

Posted byby Rishi Gupta
March 17, 2026
5 min

Amir Chand Jagdish Kumar (Exports) IPO aims to raise ₹440 crore from its market debut. The nominal value of shares is ₹10 each. The...

Posted inin IPO

Central Mine Planning & Design Institute IPO Date, Price, GMP, Details
CMPDI’s IPO opens on 20 March 2026 and closes on 24 March 2026, could this Coal India-backed issue still draw strong investor attention?

Posted byby Neha Verma
March 17, 2026
5 min

Central Mine Planning and Design Institute Limited is coming out with a book-built mainboard IPO comprising an offer for sale of 10.71 crore equity...

Posted inin Market Spotlight

Share Market News: Sensex Jumps 939 Points, Nifty Rebounds Above 23,400
Get the top stocks and market trends on StockGro for 16-March-2026. Gain insights into BSE and NSE indices and the impact of global and domestic factors.

Posted byby Priya Mehra
March 16, 2026
5 min

Nifty 50 rose 257.70 points, or 1.11%, to 23,408.80 Sensex gained 939 points, or 1.26%, to 75,502.85 The late-session surge was important because it...

Posted inin Stock Analysis Reports

Glenmark Pharmaceuticals Ltd. stock analysis & expert insights in detail
Can Glenmark’s strong specialty portfolio, expanding presence in regulated markets, focus on complex generics and branded formulations, improving margin profile, and pipeline of innovative products drive sustainable growth and long-term value creation? Let’s explore.

Posted byby Sachin Kapoor CFA (SEBI RIA)
March 16, 2026
7 min

India’s pharmaceutical sector sits at the intersection of global healthcare demand, cost-efficient manufacturing, and innovation in specialty therapies. As developed markets look to control...